IPOPLUS

741.4

-6.95 -0.93%

17 Jun 2026

NSE Listed · Pharmaceuticals

Granules India Limited (GRANULES)

Volume: 36,512Avg Vol 1W: 2,71,056Avg Vol 1M: 3,59,90652W Range:432.6804.3
₹741.4 0.93%
Market Cap₹18,984 Cr
Current Price₹741.4
Previous Close₹748.35
High / Low (52w)₹804.3 / ₹432.6
Volume36,512
Avg Vol (1W)2,71,056
Avg Vol (1M)3,59,906
Stock P/E23.55
Book Value₹205.21
Dividend Yield0.23%
ROE11.7%
ROA7.71%
Revenue (TTM)
Revenue Growth-0.55%
Profit Margin11.15%
Total Debt₹312 Cr
Shares Outstanding25 Cr
Face Value₹1
EPS (TTM)₹8.23
P/B3.68
Debt / Equity0.3
50 DMA₹761.7
200 DMA₹649.5
Day change-0.93%
Price Chart
741.4 30.92% · 1Y
7945051.2Cr
2025-10-20
2026-06-16

20-day avg volume: 3.6L shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹1,471 Cr₹1,388 Cr₹1,297 Cr₹1,210 Cr₹1,197 Cr₹1,138 Cr₹967 Cr₹1,180 Cr₹1,176 Cr₹1,156 Cr₹1,189 Cr₹986 Cr₹1,196 Cr₹1,146 Cr₹1,151 Cr₹1,020 Cr₹1,030 Cr₹997 Cr₹888 Cr₹850 Cr₹799 Cr₹845 Cr₹858 Cr₹736 Cr₹600 Cr
EBITDA₹279 Cr₹231 Cr₹205 Cr₹194 Cr₹191 Cr₹179 Cr₹154 Cr₹208 Cr₹204 Cr₹199 Cr₹162 Cr₹88 Cr₹183 Cr₹184 Cr₹204 Cr₹173 Cr₹156 Cr₹139 Cr₹116 Cr₹170 Cr₹161 Cr₹191 Cr₹224 Cr₹155 Cr₹84 Cr
Net Profit₹202 Cr₹150 Cr₹131 Cr₹113 Cr₹152 Cr₹118 Cr₹97 Cr₹135 Cr₹130 Cr₹126 Cr₹102 Cr₹48 Cr₹120 Cr₹124 Cr₹145 Cr₹128 Cr₹111 Cr₹101 Cr₹81 Cr₹120 Cr₹128 Cr₹147 Cr₹164 Cr₹111 Cr₹92 Cr
EPS8.236.195.384.646.274.854.015.555.355.184.221.984.935.15.825.134.464.053.244.855.135.96.564.363.62
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹4,495 Cr₹4,511 Cr₹4,526 Cr₹3,783 Cr₹3,264 Cr₹2,635 Cr
EBITDA₹733 Cr₹653 Cr₹743 Cr₹581 Cr₹731 Cr₹425 Cr
Net Profit₹502 Cr₹405 Cr₹517 Cr₹413 Cr₹549 Cr₹335 Cr
EPS20.6816.722116.621.9513.15
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹6,253 Cr₹5,521 Cr₹4,905 Cr₹4,513 Cr₹3,713 Cr₹3,228 Cr
Total Liabilities₹2,537 Cr₹2,295 Cr₹2,070 Cr₹1,926 Cr₹1,540 Cr₹1,385 Cr
Equity₹3,716 Cr₹3,226 Cr₹2,835 Cr₹2,587 Cr₹2,173 Cr₹1,844 Cr
Total Debt₹312 Cr₹69 Cr₹149 Cr₹234 Cr₹334 Cr₹422 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹1,010 Cr₹630 Cr₹915 Cr₹477 Cr₹624 Cr₹595 Cr
Investing₹-691 Cr₹-360 Cr₹-191 Cr₹-380 Cr₹-277 Cr₹-161 Cr
Financing₹-93 Cr₹8 Cr₹-440 Cr₹190 Cr₹-299 Cr₹-213 Cr
Free Cash Flow₹1,010 Cr₹630 Cr₹915 Cr₹477 Cr₹624 Cr₹595 Cr
Shareholding
Promoter 38.02% Institutions 32.32% Public 29.66%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search